Serum HER-2/neu has clinical utility in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzamab-based therapies Meeting Abstract
| Authors: | Cheli, C. Q.; Esteva, F. J.; Fritsche, H.; Fornier, M.; Slamon, D.; Thiel, R. P.; Lueftner, D.; Ghani, F. |
| Abstract Title: | Serum HER-2/neu has clinical utility in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzamab-based therapies |
| Meeting Title: | 57th Annual Meeting of the American Association for Clinical Chemistry |
| Journal Title: | Clinical Chemistry |
| Volume: | 51 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2005 Jul 24-28 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0009-9147 |
| Publisher: | American Association for Clinical Chemistry |
| Date Published: | 2005-06-01 |
| Start Page: | A56 |
| Language: | English |
| ACCESSION: | WOS:000229452500178 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: B-18 - 57th Annual Meeting of the American-Association-for-Clinical-Chemistry - JUL 24-28, 2005 - Orlando, FL - "6" - "Source: Wos" |
MSK Authors
-
158Fornier